nelfinavir has been researched along with salinomycin in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 1 (33.33) | 2.80 |
Authors | Studies |
---|---|
Azoulay, S; Dani, C; Darini, CY; Drici, MD; Hofman, P; Ladoux, A; Martin, P; Obba, S | 1 |
Dunlop, EA; Errington, RJ; Johnson, CE; Tee, AR; Wiltshire, M | 1 |
Aas, PA; Afset, JE; Biza, S; Bjørås, M; Erlandsen, SE; Fenstad, MH; Hagen, L; Ianevski, A; Kainov, DE; Landsem, VM; Lysvand, H; Løseth, K; Malmring, JF; Nordbø, SA; Oksenych, V; Pettersen, CH; Reisberg, T; Tenson, T; Yao, R; Zusinaite, E | 1 |
3 other study(ies) available for nelfinavir and salinomycin
Article | Year |
---|---|
Targeting cancer stem cells expressing an embryonic signature with anti-proteases to decrease their tumor potential.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Apoptosis; Cell Proliferation; Disease Progression; Drug Screening Assays, Antitumor; HIV Protease Inhibitors; Humans; Inhibitory Concentration 50; Intestinal Neoplasms; Lopinavir; Mesenchymal Stem Cells; Mice; Mice, SCID; Nelfinavir; Neoplasm Transplantation; Neoplastic Stem Cells; Pyrans; Structure-Activity Relationship; Tumor Cells, Cultured | 2013 |
Targeting protein homeostasis with nelfinavir/salinomycin dual therapy effectively induces death of mTORC1 hyperactive cells.
Topics: Animals; Cell Death; Drug Therapy, Combination; Endoplasmic Reticulum Stress; Fibroblasts; Gene Knockout Techniques; Homeostasis; Humans; Mechanistic Target of Rapamycin Complex 1; Mice; Nelfinavir; Protein Biosynthesis; Pyrans; Tuberous Sclerosis Complex 2 Protein; Tumor Suppressor Proteins | 2017 |
Potential Antiviral Options against SARS-CoV-2 Infection.
Topics: Amodiaquine; Animals; Antiviral Agents; Betacoronavirus; Caco-2 Cells; Cell Line, Tumor; Chlorocebus aethiops; Coronavirus Infections; COVID-19; COVID-19 Serotherapy; Drug Therapy, Combination; Emetine; HEK293 Cells; Homoharringtonine; HT29 Cells; Humans; Immune Sera; Immunization, Passive; Indoles; Nelfinavir; Neutralization Tests; Pandemics; Pneumonia, Viral; Pyrans; Pyrroles; SARS-CoV-2; Vero Cells | 2020 |